Literature DB >> 31665969

Defining body-weight reduction as a humane endpoint: a critical appraisal.

Steven R Talbot1, Svenja Biernot1, Andre Bleich1, Roelof Maarten van Dijk2, Lisa Ernst3, Christine Häger1, Simeon Oscar Arnulfo Helgers4, Babette Koegel3, Ines Koska2, Angela Kuhla5, Nina Miljanovic2, Franz-Tassilo Müller-Graff5, Kerstin Schwabe4, Rene Tolba3, Brigitte Vollmar5, Nora Weegh1, Tjark Wölk5, Fabio Wolf2, Andreas Wree6, Leonie Zieglowski3, Heidrun Potschka2, Dietmar Zechner5.   

Abstract

In many animal experiments scientists and local authorities define a body-weight reduction of 20% or more as severe suffering and thereby as a potential parameter for humane endpoint decisions. In this study, we evaluated distinct animal experiments in multiple research facilities, and assessed whether 20% body-weight reduction is a valid humane endpoint criterion in rodents. In most experiments (restraint stress, distinct models for epilepsy, pancreatic resection, liver resection, caloric restrictive feeding and a mouse model for Dravet syndrome) the animals lost less than 20% of their original body weight. In a glioma model, a fast deterioration in body weight of less than 20% was observed as a reliable predictor for clinical deterioration. In contrast, after induction of chronic diabetes or acute colitis some animals lost more than 20% of their body weight without exhibiting major signs of distress. In these two animal models an exclusive application of the 20% weight loss criterion for euthanasia might therefore result in an unnecessary loss of animals. However, we also confirmed that this criterion can be a valid parameter for defining the humane endpoint in other animal models, especially when it is combined with additional criteria for evaluating distress. In conclusion, our findings strongly suggest that experiment and model specific considerations are necessary for the rational integration of the parameter 'weight loss' in severity assessment schemes and humane endpoint criteria. A flexible implementation tailored to the experiment or intervention by scientists and authorities is therefore highly recommended.

Entities:  

Keywords:  distress; euthanasia; rodent; severity; stress

Mesh:

Year:  2019        PMID: 31665969     DOI: 10.1177/0023677219883319

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  8 in total

1.  Phenotyping Young GluA1 Deficient Mice - A Behavioral Characterization in a Genetic Loss-of-Function Model.

Authors:  Maria Reiber; Helen Stirling; Rolf Sprengel; Peter Gass; Rupert Palme; Heidrun Potschka
Journal:  Front Behav Neurosci       Date:  2022-06-02       Impact factor: 3.617

2.  IMB5036, a novel pyridazinone compound, inhibits hepatocellular carcinoma growth and metastasis.

Authors:  Xing Lv; Qi Zhao; Yanqun Dong; Lijun Yang; Jianhua Gong; Yanbo Zheng; Tao Yang
Journal:  Invest New Drugs       Date:  2022-01-12       Impact factor: 3.651

3.  Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment.

Authors:  Zhi Qi; Zihan Xu; Liuzhen Zhang; Yongkang Zou; Jinping Li; Wenyu Yan; Cheng Li; Ningshu Liu; Hong Wu
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

4.  Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice.

Authors:  Judit Szepesy; Viktória Humli; János Farkas; Ildikó Miklya; Júlia Tímár; Tamás Tábi; Anita Gáborján; Gábor Polony; Ágnes Szirmai; László Tamás; László Köles; Elek Sylvester Vizi; Tibor Zelles
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

5.  Development of behavioral patterns in young C57BL/6J mice: a home cage-based study.

Authors:  Maria Reiber; Ines Koska; Claudia Pace; Katharina Schönhoff; Lara von Schumann; Rupert Palme; Heidrun Potschka
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.379

Review 6.  The neurobiology of pain and facial movements in rodents: Clinical applications and current research.

Authors:  Adriana Domínguez-Oliva; Daniel Mota-Rojas; Ismael Hernández-Avalos; Patricia Mora-Medina; Adriana Olmos-Hernández; Antonio Verduzco-Mendoza; Alejandro Casas-Alvarado; Alexandra L Whittaker
Journal:  Front Vet Sci       Date:  2022-09-29

7.  Folate-Decorated Cross-Linked Cytochrome c Nanoparticles for Active Targeting of Non-Small Cell Lung Carcinoma (NSCLC).

Authors:  Irivette Dominguez-Martinez; Freisa Joaquin-Ovalle; Yancy Ferrer-Acosta; Kai H Griebenow
Journal:  Pharmaceutics       Date:  2022-02-24       Impact factor: 6.321

8.  Double-edged effects of tamoxifen-in-oil-gavage on an infectious murine model for multiple sclerosis.

Authors:  Kirsten Hülskötter; Wen Jin; Lisa Allnoch; Florian Hansmann; Daniel Schmidtke; Karl Rohn; Alexander Flügel; Fred Lühder; Wolfgang Baumgärtner; Vanessa Herder
Journal:  Brain Pathol       Date:  2021-06-17       Impact factor: 6.508

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.